{"avg":{"avg_bot_access":91.6,"avg_rendering":93,"avg_structure":35.4,"avg_schema":9.4,"avg_tech_stack":63.4,"avg_overall":56.8},"domain":{"domain":"novocure.com","crawled_at":"2026-03-15T17:36:36.754058Z","gptbot_allowed":true,"claudebot_allowed":true,"ccbot_allowed":true,"google_extended_allowed":true,"googlebot_allowed":true,"raw_text_length":2239,"rendered_text_length":2357,"ghost_ratio":0.05000000074505806,"rendering_type":"SSR","word_count":328,"li_count":39,"tr_count":0,"th_count":0,"structure_score":11.890000343322754,"has_org_schema":false,"has_product_schema":false,"schema_count":0,"tech_stack":"nextjs","server_header":"Vercel","cdn":"vercel","http_status":200,"load_time_ms":607,"total_html_bytes":560087,"useful_text_bytes":2239,"token_bloat_ratio":250.1999969482422,"images_total":0,"images_with_alt":0,"multimodal_pct":0,"tdm_reservation":false,"has_noai_tag":false,"script_bytes":451768,"has_breadcrumb_schema":false,"has_faq_schema":false,"has_article_schema":false,"has_website_schema":false,"page_title":"Novocure | cancer therapy: Tumor Treating Fields (TTFields)","meta_description":"Novocure (NASDAQ: NVCR) is an oncology company aspiring to make a difference in cancer with our novel cancer therapy Tumor Treating Fields (TTFields).","logo_url":"https://novocure.com/favicons/global-novocure/favicon.ico","crawl_blocked":false,"ai_readiness_score":74,"sub_bot_access":100,"sub_rendering":99,"sub_structure":63,"sub_schema":0,"sub_tech_stack":70,"extractability_score":44,"crawl_cost_score":100,"crawl_cost_label":"High","blocklist_risk":0,"blocklist_risk_label":"None","acri_score":44,"acri_extractability":72,"acri_semantic_structure":57,"acri_content_integrity":16,"acri_retrieval_robustness":37,"acri_grade":"D","h1_text":"together with our patients, we strive to extend survival in some of the most aggressive forms of cancer","h2_texts":"about us | our therapy | our pipeline | careers | news and media | investor relations | U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer | patient forward | social updates | Novocure Websites","tranco_rank":541756,"category":"healthcare","title_length":59,"meta_desc_length":150,"has_canonical":true,"canonical_url":"https://www.novocure.com/","canonical_mismatch":false,"has_meta_viewport":true,"h1_count":1,"h2_count":16,"h2_before_h1":false,"has_hreflang":false,"has_noindex":false,"has_lang_attr":true,"lang_attr":"en","ttfb_ms":607,"dom_node_count":647,"html_payload_kb":547,"has_hsts":true,"has_csp":true,"cache_control":"public, max-age=0, must-revalidate","sitemap_declared":true,"sitemap_url":"https://www.novocure.com/sitemap.xml","internal_links":46,"external_links":14,"tracker_scripts":0,"tracker_token_pct":0,"global_score":63,"seo_pillar":50,"geo_pillar":58,"perf_pillar":63,"arch_pillar":100,"data_tier":1,"ai_trust_score":0,"ai_trust_rank":0,"ai_trust_percentile":0,"inbound_ai_links":0,"outbound_ai_links":0,"llm_analyzed":true,"llm_analyzed_at":"2026-03-25T14:37:04.053377Z","llm_model":"mlx-community/gemma-3-4b-it-qat-4bit","ai_unified_analysis":{"core_offering":"Novocure provides a medical device and related services focused on treating glioblastoma, a deadly brain cancer, using its Temixcel drug and associated therapies.","target_audience":"Physicians, healthcare professionals, clinical trial researchers, investors, and potential investors.","pricing_model":"Not explicitly stated, but implied to be a commercial pricing model for the Temixcel drug and related services, likely involving reimbursement from healthcare systems and insurance companies.","integration_partners":[],"compliance_standards":[],"competitive_moat":"The company’s core differentiator is the Temixcel drug and its associated treatment protocol, which has demonstrated efficacy and a unique mechanism of action in glioblastoma treatment, providing a significant advantage in a challenging market.","content_depth_score":6,"key_pain_points":["Lack of explicit pricing information","Limited information on specific integration strategies beyond general contact forms"]}},"percentile":78,"similar_domains":[{"domain":"deloitte.de","acri_score":69,"ai_readiness_score":78,"tech_stack":"nextjs","category":"healthcare","token_bloat_ratio":2.200000047683716,"schema_count":0,"distance":8.75,"page_title":"Deloitte Deutschland","h1_text":"Human Capital Trends 2026"},{"domain":"atlasied.com","acri_score":69,"ai_readiness_score":76,"tech_stack":"proprietary","category":"healthcare","token_bloat_ratio":2.5999999046325684,"schema_count":0,"distance":16.75,"page_title":"Professional Audio Systems: Paging, PA System \u0026 More | AtlasIED","h1_text":""},{"domain":"louisianahealthconnect.com","acri_score":69,"ai_readiness_score":79,"tech_stack":"aem","category":"healthcare","token_bloat_ratio":1.2999999523162842,"schema_count":0,"distance":16.75,"page_title":"Louisiana Medicaid \u0026 Health Insurance Plans | Louisiana Healthcare Connections","h1_text":"One Plan."},{"domain":"orthobullets.com","acri_score":69,"ai_readiness_score":75,"tech_stack":"react","category":"healthcare","token_bloat_ratio":2.0999999046325684,"schema_count":0,"distance":16.75,"page_title":"Orthobullets - www.orthobullets.com","h1_text":""},{"domain":"bfarm.de","acri_score":69,"ai_readiness_score":78,"tech_stack":"proprietary","category":"healthcare","token_bloat_ratio":3.700000047683716,"schema_count":0,"distance":16.75,"page_title":"BfArM  -  Startseite","h1_text":"Navigation und Service"}]}